Selected References:
- Dao K, et al. 2024. Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services. BMJ Open. 14(4):e083550.
- Diab H, et al. 2024. Subcutaneous Semaglutide during Breastfeeding: Infant Safety Regarding Drug Transfer into Human Milk. 16(17):2886.
- Skov K, et al. 2023. Semaglutide and pregnancy. Int J Gynecol Obstet 163(2): 699-700.
- S. Food and Drug Administration. Ozempic product label. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209637lbl.pdf. Accessed 11 Oct 2024.
- S. Food and Drug Administration. Rybelsus product label. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213051s000lbl.pdf. Accessed 11 Oct 2024.
- S. Food and Drug Administration. Wegovy product label. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf. Accessed 11 Oct 2024.
